The investor who can fund your company is not always the investor who can help it enter the US. A useful shortlist distinguishes capital eligibility, entry stage and documented operating support.
These 15 routes span first institutional checks, seed and Series A investing, software scale-up capital and growth equity. Some explicitly specialize in transatlantic expansion; others have broader global strategies and should be evaluated accordingly. They are not interchangeable US-launch services.
Match the investor to your US expansion milestone
Define what the next round should prove. An early team learning whether US buyers have the problem is different from a company hiring to scale an existing sales motion. A growth investor may expect evidence that a seed investor is helping the company build.
- Explore: specify the target buyer, customer-learning plan and product evidence.
- Enter: show why existing demand supports a focused launch and which operating bottleneck the round resolves.
- Scale: separate realized revenue, repeatability and expansion assumptions. Pipeline is not the same as booked revenue.
Compare 15 Europe-to-US capital routes
Sources reviewed November 13, 2026. This is a curated research comparison, not a ranking or a promise of introductions. Scroll the table horizontally on mobile. The direction of expansion and the actual fund matter.
| Investor | Product focus | Stage or route | Geographic filter |
|---|---|---|---|
| Frontline Seed | B2B technology | Pre-seed and seed | European companies making the US a major market |
| Hoxton Ventures | Technology; deliberately anti-thematic | Early company investing | European startups with ambition to tackle the US early |
| Angular Ventures | Enterprise and deep technology | First institutional capital, including pre-product or pre-revenue | European and Israeli roots with US go-to-market ambition |
| Atlantic Bridge | Deep technology, computing, AI, cybersecurity and climate | Growth equity and fund-specific company stages | Europe, UK and US |
| Nauta | B2B software, enterprise technology and deep tech | Early stage with an operating product; pre-revenue can qualify | European B2B software companies |
| DN Capital | Technology businesses with global category ambition | Usually seed or Series A; capacity through Series B | Europe, North America and beyond |
| Mosaic Ventures | Applied AI; current sole focus is AI applications | Seed and Series A | European-rooted companies scaling globally, especially across the Atlantic |
| Notion Capital | Business software and native AI | Early-stage lead investing and later company development | European business-software companies with global ambitions |
| Octopus Ventures | Team-specific technology sectors | Pre-seed, seed, Series A and beyond; vehicle conditions differ | Pan-European focus with UK and US presence |
| Oxx | AI-powered applications, cybersecurity, data and vertical software | Scale-up stage after strong product-market fit | European B2B software companies |
| Point Nine | AI for digital, physical and biological applications | Early-stage company investing | Europe-based team investing globally |
| Dawn Capital | B2B software | B2B software company building; confirm current entry round | European software companies pursuing global markets |
| Kennet Partners | AI, software and AI services | Growth capital for capital-efficient companies with meaningful revenue | Europe and US |
| Alven | Technology companies; current partner and thesis fit matters | Early-stage company investing | European builders and documented European teams across Europe and the US |
| Newfund | Early technology businesses | First institutional check at pre-seed or seed | US and France; company-specific conditions |
Read provider criteria and approach routes
1. Frontline Seed
Venture investor. Frontline explicitly separates European-to-US Seed from US-to-Europe Growth. For this direction, research the Seed team and show the US customer opportunity. Its expansion playbook and operator network are documented support, not a guarantee of customers or a US financing round.
Founder route: Official investment-team information; an open application is not implied. Official criteria · Supporting official evidence.
2. Hoxton Ventures
Venture investor. Hoxton's stated approach encourages European companies to pursue the US market early. Explain why the product can win there and what evidence the next round will establish. Its Silicon Valley relationships are a reason to research fit, not a promise that every portfolio company receives the same introductions.
Founder route: Official investment-team information; an open application is not implied. Official criteria · Supporting official evidence.
3. Angular Ventures
Venture investor. Angular combines early technical conviction with an explicit transatlantic company-building model. It can be relevant before a company has a mature US sales operation. Show the technical insight and target buyer, then distinguish a future US ambition from customers already secured.
Founder route: Official investment-team information; an open application is not implied. Official criteria.
4. Atlantic Bridge
Venture investor. Atlantic Bridge documents a cross-border value-add strategy and teams on both sides of the Atlantic. Its main growth-equity strategy is not the same as an affiliated university-stage vehicle. Identify the correct fund and stage before asking for expansion support.
Founder route: Official investment-team information; an open application is not implied. Official criteria · Supporting official evidence.
5. Nauta
Venture investor. Nauta's current company criteria and published US-expansion work offer two useful screens: product readiness and a credible expansion plan. A founder should explain the US customer job and what is already working in Europe. An expansion workshop is context, not a guaranteed service package.
Founder route: Official investment-team information; an open application is not implied. Official criteria · Supporting official evidence.
6. DN Capital
Venture investor. DN describes a transatlantic approach and practical support around customers, hiring and later financing. Explain which bottleneck the company needs to solve first. A global ambition should be backed by a specific market thesis, not only a larger addressable-market slide.
Founder route: Official investment-team information; an open application is not implied. Official criteria.
7. Mosaic Ventures
Venture investor. Mosaic's current strategy is applied AI, not an unrestricted generalist software mandate. Its stated transatlantic experience can fit a European AI company planning US growth. Explain the application-layer advantage and stage evidence before treating a historical non-AI investment as a current entry policy.
Founder route: Official investment-team information; an open application is not implied. Official criteria.
8. Notion Capital
Venture investor. Notion combines an early European software focus with a portfolio-support platform and transatlantic expertise. Match the actual business model and revenue-building stage. Research the relevant partner and support need rather than assume that a public adviser profile creates an open service for non-portfolio companies.
Founder route: Official investment-team information; an open application is not implied. Official criteria · Supporting official evidence.
9. Octopus Ventures
Venture investor. Octopus publishes both investment-process criteria and a US-expansion planning resource. Its pre-seed and later-stage routes have different lead and follow-on behavior. Identify the right stage and sector team before using the expansion resource to frame a conversation.
Founder route: Official investment-team information; an open application is not implied. Official criteria · Supporting official evidence.
10. Oxx
Venture investor. Oxx focuses on software companies ready to scale rather than idea-stage US exploration. Its internationalization material helps frame the go-to-market decision. Show a working product, proven market fit and the commercial evidence for expansion; do not pitch a pre-seed company as a scale-up.
Founder route: Official investment-team information; an open application is not implied. Official criteria · Supporting official evidence.
11. Point Nine
Venture investor. Point Nine's current public strategy is global and AI-focused. It is a capital-fit option for an aligned European company, not a documented dedicated US-launch program. Ask what support is available for the actual expansion bottleneck rather than infer a service from the firm's global portfolio.
Founder route: Official investment-team information; an open application is not implied. Official criteria.
12. Dawn Capital
Venture investor. Dawn's US Launchpad documents expansion and hiring work for European founders. That is useful evidence of relevant operating support. Match the company's current stage to the investment team and be precise about whether the next round funds initial market learning or scaling an existing US motion.
Founder route: Official investment-team information; an open application is not implied. Official criteria · Supporting official evidence.
13. Kennet Partners
Growth-equity investor. Kennet targets businesses with commercial proof rather than an untested US launch. Its Europe-and-US platform can be relevant when a lightly funded company needs growth capital for expansion. The founder should present the existing revenue engine and the US plan separately.
Founder route: Official investment-team information; an open application is not implied. Official criteria · Supporting official evidence.
14. Alven
Venture investor. Alven's record includes backing European teams across both markets. Use that as company-building context, not proof of a standardized expansion program. Explain the founder and product fit, then ask about the actual US operating support available for the proposed round.
Founder route: Official investment-team information; an open application is not implied. Official criteria · Supporting official evidence.
15. Newfund
Venture investor. Newfund's US-and-France focus creates a distinct bilateral route rather than a general all-Europe mandate. French founders can research its first-institutional-check approach and transatlantic team. Companies elsewhere should confirm eligibility instead of treating a broad European expansion ambition as enough.
Founder route: Official investment-team information; an open application is not implied. Official criteria · Supporting official evidence.
Compare support, not just office addresses
A US address can be useful context, but it is not an expansion service. Look for an explicit cross-border investment model, relevant operating-team expertise, published playbooks or a clearly documented support platform. Then ask which help is actually available to a company at your stage.
Keep the support need specific: customer learning, a senior commercial hire, partner introductions, positioning or a later financing conversation. An investor can be a good source of capital without being the best provider of each task. Ask portfolio founders what support they actually received rather than assume public marketing describes every engagement.
Company structure, employment, visas and tax create separate decisions. Use qualified advisers for those matters; this directory is about investor research and expansion planning, not a recommendation to relocate or restructure.
A worked shortlist for a European B2B company
Fictional example: Cedar Ops has paying European customers and several US design partners. It is preparing a seed round to test a focused US sales motion. The founders first investigate Frontline Seed's stated direction, Hoxton's early US ambition and Angular if the enterprise/deep-tech thesis fits.
They exclude Frontline Growth because its direction is the reverse. They also avoid presenting the company to a post-product-market-fit growth strategy as though design partners establish repeatable US revenue. Each retained investor gets a short evidence brief and one question about the actual support needed.
Copy the expansion investor-fit worksheet
Keep the source, market evidence, relationship context and next action connected in Finta. Use one record per investing platform, not per office.
EUROPE-TO-US EXPANSION INVESTOR-FIT WORKSHEET
Company / European operating base / product:
US buyer and specific customer job:
Stage of expansion: explore / enter / scale
European evidence versus actual US evidence:
Next milestone and work financed by the round:
Investor / actual fund / entry stage:
Geography and direction of expansion:
Support evidence: explicit program / team expertise / resource / not established
Specific support needed and question to ask:
Public approach route / relationship context:
Separate adviser questions, without assuming a restructuring decision:
Responsible owner / next action / review date:Ask Aurora, Claude or Codex to review your shortlist
Supply your facts and the official sources. Review the result before acting; this is a research aid, not automatic outreach.
Compare my Europe-to-US expansion investor shortlist from the official sources I provide.
Company facts: [product, European base, target US buyer, stage, actual evidence, round and next milestone].
Separate investor eligibility, entry stage and documented operating support. Distinguish Europe-to-US from US-to-Europe strategies and capital fit from a guaranteed expansion service. Treat office locations and historical holdings as context, not sufficient proof of eligibility. Mark unknowns, reject stage mismatches and return a short research queue with evidence, exclusions and specific support questions. Keep legal, tax, immigration and employment decisions separate for qualified advisers. Do not send outreach or promise funding, introductions or customers.Methodology and related resources
The Finta Editorial Team reviewed current investor-controlled strategy, criteria, support resources, team and contact pages. We separate explicit transatlantic specialists from broader global investors, label growth equity and count each platform once. Published support resources are not promises of an identical service to every company.
Use the seed fundraising comprehensive guide for the round process. Compare pre-seed B2B SaaS investors when entry stage is the main decision and first-institutional-round investors when financing history changes the shortlist.
This is general research and organizational information, not individualized financial, legal, tax or immigration advice.